CRISAL Study:Cancer Risk In Secreting Adrenal Lesions

Launched by UNIVERSITY OF ROMA LA SAPIENZA · Jul 19, 2024

Keywords

ClinConnect Summary

The CRISAL Study is researching the risk of cancer in patients with adrenal lesions that produce hormones, known as secreting adrenal lesions, compared to those that do not. The study aims to find out if the activity of these hormones can help predict whether a lesion is cancerous. Additionally, it will look at how patients do during and after surgery for these lesions, and whether one type of minimally invasive surgery is better than the others.

To participate, you must be at least 18 years old and need to have planned surgery to remove an adrenal lesion. The study is currently recruiting participants of all genders. If you join, you can expect to undergo the usual pre-surgery evaluations and be closely monitored during and after your operation, helping researchers understand more about these types of adrenal tumors. Remember, pregnant individuals or those needing emergency surgery cannot participate in this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing elective adrenalectomy;
• • Patients aged ≥ 18 years
• • Acceptance of informed consent
• Exclusion Criteria:
• • Patients undergoing emergency adrenalectomy;
• • Patients aged ≤ 18 years
• • Pregnant patients